Science’s 2023 Breakthrough of the Year: GLP-1 agonists show promise for obesity-associated health problems
Science has named the development of glucagon like peptide-1 (GLP-1) agonists and this year’s discovery that these drugs can blunt obesity-associated health problems as its 2023 Breakthrough of The… read more.
